FindTrial
Sign In

Comparing two different combination of medicines given just before incision of abdomen surgery

Comparision of efficacy of Bupivacaine plus Tramadol with Bupivacaine plus Dexmedetomidine as preincisional infiltration in patients undergoing abdominal surgery under general anaesthesia : A Prospective Randomised Double Blinding Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/05/019201
Enrollment
60
Registered
2019-05-16
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 3- Administration

Interventions

Intervention1: Dexmedetomidine and Bupivacaine: 1 mcg/kg Dexmedetomidine in 0.2 ml/kg of 0.25% Bupivacaine Route - Subcutaneous local infiltration Frequency - once Duration - 1 to 2 minutes Control

Sponsors

Indira Gandhi Institute of Medical Sciences
Lead Sponsor
Dr Ajit Kumar
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Patients of ASA physical status 1 and 2 Patients willing to participate Patients undergoing abdominal surgery

Exclusion criteria

Exclusion criteria: Patients refusal to participate Patients with pregnancy, morbid obesity, full stomach and emergency surgery Patients with ASA physical status 3 and above

Design outcomes

Primary

MeasureTime frame
To compare the efficacy of Bupivacaine plus tramadol vs Bupivacaine plus dexmedetomidine as preincisional infiltration.Timepoint: From administration of drug to upto 24 hours after surgery—

Secondary

MeasureTime frame
To compare the post operative effect of analgesia in both groups.Timepoint: From administration of drug to upto 24 hours after surgery—

Countries

India

Contacts

Public ContactDr Vinod Kumar Verma

Indira Gandhi Institute of Medical Sciences

drvvinodv@gmail.com9473191825

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026